Is Syra Health Corp’s (NASDAQ: SYRA) 3.72% Gain This Week Telling Us Something New?

During the recent session, Syra Health Corp (NASDAQ:SYRA)’s traded shares were 18.07 million, with the beta value of the company hitting 4.28. At the last check today, the stock’s price was $0.43, reflecting an intraday gain of 9.47% or $0.04. The 52-week high for the SYRA share is $3.28, that puts it down -662.79 from that peak though still a striking 20.93% gain since the share price plummeted to a 52-week low of $0.34. The company’s market capitalization is $5.22M, and the average intraday trading volume over the past 10 days was 0.17 million shares, and the average trade volume was 1.74 million shares over the past three months.

Syra Health Corp (NASDAQ:SYRA) trade information

Syra Health Corp (SYRA) registered a 9.47% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 9.47% in intraday trading to $0.43, hitting a weekly high. The stock’s 5-day price performance is 3.72%, and it has moved by -12.53% in 30 days. Based on these gigs, the overall price performance for the year is -87.09%. The short interest in Syra Health Corp (NASDAQ:SYRA) is 0.46 million shares and it means that shorts have 0.1 day(s) to cover.

Syra Health Corp (SYRA) estimates and forecasts

In the rating firms’ projections, revenue will increase 44.83% compared to the previous financial year.

As companies strive to predict their financial trajectories, we turn our attention to the forthcoming financial quarter. Here are the insights gathered from industry analysts. Revenue for the current quarter is expected to be 2.01M as predicted by 1 analyst(s).

SYRA Dividends

Syra Health Corp is due to release its next quarterly earnings in March. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.

Syra Health Corp (NASDAQ:SYRA)’s Major holders

Also, the Mutual Funds coming in first place with the largest holdings of Syra Health Corp (SYRA) shares are Vanguard Extended Market Index Fund and Fidelity Extended Market Index Fund. Data provided on Sep 30, 2024 indicates that Vanguard Extended Market Index Fund owns about 34.25 shares. This amounts to just over 0.30 percent of the company’s overall shares, with a $14037.0 market value. The same data shows that the other fund manager holds slightly less at 21.45, or about 0.19% of the stock, which is worth about $8793.0.